News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Brandon Imber: Effective cytoreduction improves outcomes for CAR T cell patients
Oct 18, 2024, 16:08

Brandon Imber: Effective cytoreduction improves outcomes for CAR T cell patients

Brandon Imber, Radiation Oncologist at Memorial Sloan Kettering Cancer Center, posted the following on X:

“Effective cytoreduction in the bridging period can significantly improve outcomes for those planned for CAR T cells – radiotherapy is a particularly effective tool for highest-risk patients!”

Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B cell lymphoma

Authors: Harper Hubbeling, Doris Leithner, Emily A Silverman, Jessica Flynn, Sean Devlin, Gunjan Shah, Beatrice Fregonese, Beatriz Wills, Akshay Bedmutha, Ana Alarcon Tomas, Allison Parascondola, Amethyst Saldia, Ivan Landego, Carla Hajj, Alexander P Boardman, Parastoo B Dahi, Arnab Ghosh, Sergio Giralt, Richard J Lin, Jae Park, Michael Scordo, Gilles Salles, Joachim Yahalom, M Lia Palomba, Heiko Schöder, Miguel-Angel Perales, Roni Shouval, Brandon S Imber

Brandon Imber: Effective cytoreduction improves outcomes for CAR T cell patients

AACR Akshay Bedmutha Alexander P. Boardman Allison Parascondola Amethyst Saldia Ana Alarcon Tomas Arnab Ghosh Beatrice Fregonese Beatriz Wills Brandon Imber Brandon S. Imber cancer CAR- therapy CAR-T cells Carla Hajj CCR Cytoreduction Doris Leithner Emily A Silverman Gilles Salles Gunjan Shah Harper Hubbeling Heiko Schoder ILROG Ivan Landego Jae Park Jessica Flynn Joachim Yahalom M Lia Palomba Michael Scordo Miguel-Angel Perales MSK MSK Cancer Center OncoDaily Oncology Parastoo B Dahi patient outcomes radiotherapy RadOnc Richard J Lin Roni Shouval Sean Devlin Sergio Giralt Treatment Strategies
Special Coverage
Blog
Dec 21, 2024, 09:00
Miriam Mutebi: Does Nipple and Areola Size Matter?
Science
Dec 21, 2024, 08:51
Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis
Science
Dec 21, 2024, 08:48
Oncology Brothers: Another ALK inhibitor gets FDA approval
Science
Dec 21, 2024, 08:42
Eric K. Singhi: Decoding clinical trial jargon
Science
Dec 21, 2024, 08:37
Gustavo Viani: The Role of Radiotherapy on the management of HCC
Science
Dec 21, 2024, 08:29
Bishal Gyawali: The case of cancer drug Xtandi
Blog
Dec 21, 2024, 08:18
Sami (Papacek) Mansfield: Why is muscle health so important among cancer survivers?
Career
Dec 21, 2024, 08:12
Rishabh Singh: Honored to receive the Mary Draeger Schultz Scholarship 2024
Science
Dec 21, 2024, 07:56
Predictors of Discharge With Supplemental Oxygen After Lobectomy for Lung Cancer
Career
Dec 21, 2024, 07:45
OncoInfluencers to Follow on Social Media: Dr. Liang Cheng
Insight
Dec 21, 2024, 07:31
Update on U.S. regulatory review of subcutaneous amivantamab for EGFR + lung cancer
Science
Dec 21, 2024, 07:05
Naseema Gangat: Practical prognostic tool for the current standard of care in older/unfit AML